Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2023 | Epigenetic drivers of disease progression in multiple myeloma

In this video, Felipe Prosper, MD, PhD, University of Navarra, Pamplona, Spain, discusses the role of epigenetics in the pathogenesis of multiple myeloma, highlighting novel transcription factors that have been identified and may play a role in disease progression, including IRF-2. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.